Recap: Verrica Pharmaceuticals Q1 Earnings

Verrica Pharmaceuticals VRCA reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM.

Here's what investors need to know about the announcement.


Verrica Pharmaceuticals beat estimated earnings by 31.58%, reporting an EPS of $-0.13 versus an estimate of $-0.19.

Revenue was down $394 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 7.7% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Verrica Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.


Analyst Ratings




Posted In: EarningsBZI-Recaps